CTKB - Utang jangka dawa perusahaan Cytek Bio

Cytek Biosciences, Inc. (CTKB) develops unique systems for spectral cell analysis, utilizing proprietary software to outperform laser-based methods. The company's environmental approach is based on chemical recycling and plastic reduction, while current price action reflects the value of 0.02. The business model's revenues rely on the supply of high-tech cytometers to medical centers and pharmaceutical laboratories for immunological research and diagnostics.

Cytek Biosciences, Inc. (CTKB) incurs high development costs for laser diagnostic systems and cytometry software, necessitating significant external financing. This metric captures total liabilities with maturities exceeding one year, allowing investors to assess debt load risk amid fluctuating interest rates by analyzing the organization's long-term financial debt history to determine the sustainability of the business model.